<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Akero Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Akero Therapeutics, Inc.

    Akero aims to develop and deliver transformational medicines to patients with high unmet medical need. Akero’s current focus is advancing our lead program, AKR-001, to provide a powerful new therapy for patients with NASH (non-alcoholic steatohepatitis). Akero is led by industry veterans with decades of experience delivering innovative medicines to patients. We are united in our commitment to developing transformational new therapies for NASH and other serious metabolic diseases. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $432,700,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Andrew Cheng
    • FOUNDED
      2017
    • EMPLOYEES
      0-10
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Compugen Ltd.

    Compugen Ltd.

    Compugen is a drug discovery company with a unique, broadly applicable, predictive...

    Compugen is a drug discovery company with a uni...

    Filing Type:    PU
    NextCure, Inc.

    NextCure, Inc.

    NextCure is a clinical-stage biopharmaceutical company committed to discovering an...

    NextCure is a clinical-stage biopharmaceutical ...

    Filing Type:    PU
    Genmab A/S

    Genmab A/S

    Genmab is a publicly traded, international biotechnology company specializing in t...

    Genmab is a publicly traded, international biot...

    Filing Type:    PU
    Eiger BioPharmaceuticals, Inc.

    Eiger BioPharmaceuticals, Inc.

    Eiger is a late stage biopharmaceutical company focused on the development and com...

    Eiger is a late stage biopharmaceutical company...

    Filing Type:    PU
    Marker Therapeutics, Inc.

    Marker Therapeutics, Inc.

    We are a clinical-stage immuno-oncology company specializing in the development an...

    We are a clinical-stage immuno-oncology company...

    Filing Type:    PU
    Selecta Biosciences, Inc.

    Selecta Biosciences, Inc.

    Selecta Biosciences, Inc. is a clinical-stage biotechnology company focused on unl...

    Selecta Biosciences, Inc. is a clinical-stage b...

    Filing Type:    PU
    GENFIT S.A.

    GENFIT S.A.

    GENFIT is a late-stage biopharmaceutical company dedicated to the discovery and de...

    GENFIT is a late-stage biopharmaceutical compan...

    Filing Type:    PU
    NGM Biopharmaceuticals, Inc.

    NGM Biopharmaceuticals, Inc.

    We are a clinical stage biopharmaceutical company focused on harnessing powerful b...

    We are a clinical stage biopharmaceutical compa...

    Filing Type:    PU
    Gilead Sciences, Inc.

    Gilead Sciences, Inc.

    Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers...

    Gilead Sciences, Inc. is a research-based bioph...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.